In one longitudinal study, complement effect proteins C4b, C3d, Factor B, Bb, C3b, and C5b-C9 TCC increased in blood ADsEVs of patients with AD, while complement regulatory proteins CD59 and DAF decreased, consistent with the directional changes observed in NDsEVs. The gene discussed is C9; the disease is Alzheimer disease.